{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:50:02Z","timestamp":1785880202161,"version":"3.56.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006546","name":"Angelini ACRAF SpA Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006546","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.seizure.2026.06.005","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:04:02Z","timestamp":1781827442000},"page":"184-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Unlocking seizure freedom: A European Delphi panel study on the clinical, humanistic, and economic value of seizure control in epilepsy"],"prefix":"10.1016","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4180-8896","authenticated-orcid":false,"given":"P.","family":"Boon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"House","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"M\u2019Rabet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Marcellusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8610-1467","authenticated-orcid":false,"given":"J.","family":"Poza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Sofia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3619-8234","authenticated-orcid":false,"given":"P.","family":"Tittensor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Pavisic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2895-2443","authenticated-orcid":false,"given":"C.","family":"V\u00e1zquez \u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sgarbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4905-3704","authenticated-orcid":false,"given":"E.","family":"Stamuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0812-0352","authenticated-orcid":false,"given":"M.C.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.seizure.2026.06.005_bib0001","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1528-1167.2006.00585.x","article-title":"ILAE Treatment Guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes","volume":"47","author":"Glauser","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2026.06.005_bib0002","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-0-387-98188-8_8","article-title":"The impact of epilepsy on quality of life","author":"Vaurio","year":"2017","journal-title":"Chang Brain: Impact Dly Life"},{"issue":"4","key":"10.1016\/j.seizure.2026.06.005_bib0003","article-title":"Treatments for the prevention of sudden unexpected death in epilepsy (SUDEP)","volume":"2020","author":"Maguire","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"S1","key":"10.1016\/j.seizure.2026.06.005_bib0004","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/epi.18307","article-title":"Seizure freedom and reducing the risk of sudden unexpected death in patients with focal epilepsy treated with cenobamate or other antiseizure medications","volume":"66","author":"Sperling","year":"2025","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.seizure.2026.06.005_bib0005","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1080\/14737175.2018.1439738","article-title":"Identifying and mitigating sudden unexpected death in epilepsy (SUDEP) risk factors","volume":"18","author":"Watkins","year":"2018","journal-title":"Expert Rev Neurother"},{"issue":"4","key":"10.1016\/j.seizure.2026.06.005_bib0006","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.yebeh.2007.12.019","article-title":"The global burden and stigma of epilepsy","volume":"12","author":"Boer","year":"2008","journal-title":"Epilepsy Behav"},{"issue":"2","key":"10.1016\/j.seizure.2026.06.005_bib0007","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/ane.13257","article-title":"Seizure freedom as an outcome in epilepsy treatment clinical trials","volume":"142","author":"Halford","year":"2020","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"10.1016\/j.seizure.2026.06.005_bib0008","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug Resistant epilepsy: consensus proposal by the Ad Hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.seizure.2026.06.005_bib0009","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1528-1167.2011.03355.x","article-title":"Revising the \u2018rule of three\u2019 for inferring seizure freedom","volume":"53","author":"Brandon Westover","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2026.06.005_bib0010","unstructured":"European Medicines Agency (EMA). 2010. \u201cClinical investigation of medicinal products in the treatment of epileptic disorders - scientific guideline\u201d."},{"key":"10.1016\/j.seizure.2026.06.005_bib0011","unstructured":"FDA, Food and Drug Administration, Center for Drug Evaluation and. 1981. \u201cClinical evaluation of antiepileptic drugs (Adults and Children).\u201d FDA. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/clinical-evaluation-antiepileptic-drugs-adults-and-children."},{"key":"10.1016\/j.seizure.2026.06.005_bib0012","unstructured":"EMA, European Medicines Agency. 2025. \u201cGuideline on clinical investigation of medicinal products in the treatment of epileptic disorders\u201d."},{"key":"10.1016\/j.seizure.2026.06.005_bib0013","article-title":"Epilepsies: diagnosis and management","year":"2016","journal-title":"Draft Guidel [NG217]"},{"key":"10.1016\/j.seizure.2026.06.005_bib0014","series-title":"Brivaracetam \u2013 extract of dossier assessment A16-08","year":"2016"},{"key":"10.1016\/j.seizure.2026.06.005_bib0015","unstructured":"NICE. 2021. \u201cCenobamate for treating focal onset seizures in epilepsy [TA753]\u201d."},{"issue":"4","key":"10.1016\/j.seizure.2026.06.005_bib0016","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/epd2.20243","article-title":"Outpatient management of prolonged seizures and seizure clusters to prevent progression to a higher-level emergency: consensus recommendations of an expert working group","volume":"26","author":"Pina-Garza","year":"2024","journal-title":"Epileptic Disord: Int Epilepsy J Videotape"},{"issue":"2","key":"10.1016\/j.seizure.2026.06.005_bib0017","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4097\/kja.21426","article-title":"Delphi consensus on the American Society of Anesthesiologists\u2019 Physical Status Classification in an Asian Tertiary Women\u2019s hospital","volume":"75","author":"Osman","year":"2022","journal-title":"Korean J Anesth"},{"key":"10.1016\/j.seizure.2026.06.005_bib0018","article-title":"Thematic analysis","volume":"2","author":"Braun","year":"2012"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131126001779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131126001779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:25:46Z","timestamp":1785878746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131126001779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":18,"alternative-id":["S1059131126001779"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2026.06.005","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unlocking seizure freedom: A European Delphi panel study on the clinical, humanistic, and economic value of seizure control in epilepsy","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2026.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of British Epilepsy Association.","name":"copyright","label":"Copyright"}]}}